An official website of the United States government
Login Change: CDAS is now using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.
This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes (1) this computer network, (2) all computers connected to this network, and (3) all devices and storage media attached to this network or to a computer on this network.
This system is provided for Government-authorized use only.
Unauthorized or improper use of this system is prohibited and may result in disciplinary action and/or civil and criminal penalties.
Personal use of social media and networking sites on this system is limited as to not interfere with official work duties and is subject to monitoring.
By using this system, you understand and consent to the following:
The Government may monitor, record, and audit your system usage, including usage of personal devices and email systems for official duties or to conduct HHS business. Therefore, you have no reasonable expectation of privacy regarding any communication or data transiting or stored on this system. At any time, and for any lawful Government purpose, the government may monitor, intercept, and search and seize any communication or data transiting or stored on this system.
Any communication or data transiting or stored on this system may be disclosed or used for any lawful Government purpose.
No Self Report/Unconfirmable Lung Cancer in Controls
Serum Available
Pre-Diagnostic Serum Available
Serum Available 1-10 Years Before Diagnosis
Cases With Similar Time from Draw to Diagnosis as Cases in 2009-00516
Matching Factors:
Gender
Age at Randomization (5 year intervals)
Calendar Year of Blood Draw (2 year intervals)
Study Year of Blood Draw
Smoking History
Years Since Quit Smoking (<15, 15+)
Pack Years Smoked (<30, 30-40, 40-50,50+)
Match Ratio: 1:1 for ever smokers, 3:1 for never smokers
Match Technique: Individual matching only non-cases as controls.
Additional Matching Comments: GWAS controls were rematched to selected controls without a GWAS on all matching factors, as well as race (3 levels) and cancer experience.
Analytes:
B-Cell Attracting Chemokine 1
Basic Fibroblast Growth Factor
C-Reactive Protein
Chemokine (C-C Motif) Ligand 13
Chemokine (C-C Motif) Ligand 19
Chemokine (C-C Motif) Ligand 2
Chemokine (C-C Motif) Ligand 20
Chemokine (C-C Motif) Ligand 21
Chemokine (C-C Motif) Ligand 22
Chemokine (C-C Motif) Ligand 27
Chemokine (C-C Motif) Ligand 8
Chemokine (C-X-C Motif) Ligand 1
Chemokine (C-X-C Motif) Ligand 10
Chemokine (C-X-C Motif) Ligand 11
Chemokine (C-X-C Motif) Ligand 12
Chemokine (C-X-C Motif) Ligand 5
Chemokine (C-X-C Motif) Ligand 6
Chemokine (C-X-C Motif) Ligand 9
Eotaxin
Eotaxin-2
Epidermal Growth Factor
Granulocyte-Colony Stimulating Factor
Interleukin 1
Interleukin 1 Receptor Antagonist
Interleukin 16
Interleukin 29
Interleukin 3
Interleukin 33
Interleukin 7
Interleukin 8
Macrophage Inflammatory Protein 1 delta
Macrophage inflammatory protein 1 beta
Serum Amyloid A
Serum Amyloid P
Soluble Epidermal Growth Factor Receptor
Soluble Interleukin 4 Receptor
Soluble Interleukin 6 Receptor
Soluble Interleukin 6 beta
Soluble Tumor Necrosis Factor Receptor I
Soluble Tumor Necrosis Factor Receptor II
Stem Cell Factor
Thrombopoietin
Thymic Stromal Lymphopoietin
Thymus and Activation Regulated Chemokine
Transforming Growth Factor Alpha
Tumor Necrosis Factor Alpha 1
Tumor Necrosis Factor Beta
Tumor Necrosis Factor Receptor Superfamily, Member 10
Vascular Endothelial Growth Factor
Vascular endothelial growth factor receptor 2
Vascular endothelial growth factor receptor 3
Number of Cases: 526
Number of Controls: 626
The following datasets contain the data available for 2012-0356. The description and documentation for each file is listed below. SAS7bdat and CSV versions of the actual data will be available to CDAS projects approved to use this data.
